Editas Medicine EDIT Q1 2025 earnings
Reported May 12, 2025 · After market close
Revenue$4.7MBeat by $4.0M
EPS-$0.43Beat by $0.08
Revenue estimate$706.1K
EPS estimate-$0.51
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$2.8M
EPS estimate-$0.30
Versus estimates
Revenue
Diluted EPS
Ask the moment Editas Medicine reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Editas Medicine report Q1 2025 earnings?
- Editas Medicine (EDIT) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Editas Medicine's Q1 2025 revenue and EPS?
- Editas Medicine reported revenue of $4.7M and eps of $-0.43 for Q1 2025.
- Did Editas Medicine beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $706.1K by $4.0M. EPS beat the consensus estimate of $-0.51 by $0.08.
- How did Editas Medicine's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 310.4% from $1.1M a year earlier and eps grew 43.4% from $-0.76.
- Where can I find Editas Medicine's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001650664-25-000073) directly on SEC EDGAR. The filing index links above go to sec.gov.